INSIGHTS ON CLINICAL TRIAL PARTNERING

• What Sponsors Get Wrong When Selecting A CRO

  Gene therapy immunogenicity requires platforms, judgment, and regulatory fluency beyond ADA norms. Relying on biologics criteria creates gaps; CGT expertise ensures reliable, interpretable results.

• Optimizing Clinical Supply Flexibility With Demand-Led Strategies

  Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.

• How Many Vendors Does One Trial Really Need?

  Operational friction can hinder trial performance. Discover how centralizing key functions improves coordination, lowers administrative burden, and enhances stakeholder experiences.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

• Dedicated Community Oncology Sites

  7/29/2026

  Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.

• Executing Pediatric Gene Therapy Trials At The Site Level

  5/29/2026

  Pediatric gene therapy trials demand exceptional coordination at the site level, and these frontline insights can help you manage protocol complexity and balance operations with family‑centered care.

• Accelerating Parkinson's Disease Clinical Research Through Recruitment Capabilities

  1/14/2026

  Centralized PD trials cut variability, speed enrollment, and enable genetic stratification, delivering high‑quality data and faster progress from early‑phase research to late‑stage development.

• Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study

  1/6/2025

  Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

• Benefit From Enhanced Power And Intelligence

  8/14/2025

  Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.